CANbridge Pharmaceuticals Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-136.11	-442.62	-378.84	-483.48	-1,077	-846.04
Depreciation & Amortization	19.86	27.16	28.34	21.92	15.67	17.82
Other Amortization	0.09	0.09	0.12	0.06	0.03	0.02
Loss (Gain) From Sale of Assets	-98.27	-2.23	2.01	1.25	-9.73	-
Asset Writedown & Restructuring Costs	64.34	89.41	4.01	-	-	-
Stock-Based Compensation	6.68	7.69	19.92	26.82	30.51	14.66
Other Operating Activities	7.44	15.63	18.13	33.5	430.43	615.9
Change in Accounts Receivable	21.2	14.64	-12.17	-9.91	-2.1	-6.6
Change in Inventory	-12.03	0.88	1.04	3.62	-12.9	0.07
Change in Accounts Payable	81.59	165.09	90.51	63.93	-3.11	40.59
Change in Other Net Operating Assets	22.29	1.87	-51.3	61.31	41.12	11.95
Operating Cash Flow	-22.92	-122.4	-278.23	-280.98	-587.07	-151.65
Capital Expenditures	-0.1	-0.11	-5.14	-15.2	-5.09	-2.57
Sale of Property, Plant & Equipment	1.03	0.03	-	-	-	-
Sale (Purchase) of Intangibles	-	-	-35.33	-0.14	131.18	-150.91
Sale (Purchase) of Real Estate	-	14.01	14.01	-	-	-
Other Investing Activities	-	-	-0.38	-19.45	-	-
Investing Cash Flow	0.93	13.93	-26.86	-34.79	126.09	-153.48
Long-Term Debt Issued	-	27.93	19.8	38.63	20.76	21.53
Long-Term Debt Repaid	-	-45.08	-45.77	-43.31	-32.08	-18.07
Net Debt Issued (Repaid)	-23.97	-17.15	-25.97	-4.68	-11.32	3.46
Issuance of Common Stock	-	0.04	0.08	0.03	563.8	0.99
Other Financing Activities	-7.19	-1.45	-2.13	-16.06	-33.07	9.11
Financing Cash Flow	-31.16	-18.57	-28.02	-20.7	854.31	679.26
Foreign Exchange Rate Adjustments	-0.4	0.05	6.85	41.81	-8.32	-27.2
Net Cash Flow	-53.54	-126.99	-326.26	-294.66	385.01	346.93
Free Cash Flow	-23.02	-122.5	-283.38	-296.18	-592.16	-154.22
Free Cash Flow Margin	-36.80%	-143.94%	-275.47%	-375.04%	-1900.31%	-1281.74%
Free Cash Flow Per Share	-0.05	-0.29	-0.67	-0.70	-6.28	-2.25
Cash Interest Paid	0.79	1.45	1.49	2.17	1.38	4.99
Levered Free Cash Flow	36.48	16.48	-202.09	-142.04	-207.98	-225.19
Unlevered Free Cash Flow	40.1	21.84	-196.5	-137.75	-206.05	-222.82
Change in Working Capital	113.05	182.48	28.08	118.95	23.02	46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.